A new dual hepatocyte-targeting fluorescent probe HPL-1, which can precisely distinguish tumorous pH from physiological pH, was developed. The OFF-ON switch of HPL-1 can be triggered via pH-induced structural change of the lactam group of the rhodamine moiety from closed-ring to open-ring. Our results showed that the phosphate group of HPL-1 is beneficial to its accumulation in liver cells, and combination of the phosphate and galactose units could synergistically increase the hepatocyte-targeting capacity. HPL-1 could selectively distinguish hepatoma cells from other tissue cells, and precisely distinguish cancerous liver cells from normal liver cells. Compared with other reported probes, HPL-1 not only enable a simple and convenient detection method, but also has good hepatocyte-targeting capacity and precise recognition capacity of tumors under weak acid micro-environment, which opens new avenues for precise diagnosis and treatment of hepatocellular carcinoma. 
Introduction
Hepatocellular carcinoma (HCC) is one of the most dangerous malignancies associated with high incidence and low survival rate 1, 2 . HCC is often diagnosed at the advanced stage 3 , when the surgical removal is not applicable any more. Therefore, considerable efforts have been devoted to the early and accurate detection of HCC, and a series of biomarkers have been developed for the specific recognition of HCC 4 .
However, while these methods could partially identify cancer cells, they suffer from some drawbacks such as the complex pretreatment, high cost, time-consuming, or difficult for storing. It has been well-known that the pH value of tumorous micro-environment (6.2~6.9) 5, 6 is slightly lower than that of physiological micro-environment (7.2~7.4) 7 and this phenomenon has arisen from the unlimited propagation of cancer cells in the oxygen-deficient environment. Therefore, precise differentiation of the subtle pH value change would provide an ideal and practical approach to distinguish cancerous cells from normal cells. Rhodamines [8] [9] [10] [11] , naphthalimides 12, 13 , benzoindole [14] [15] [16] , and a series of nanomaterials 17 are well-established pH-responsive probes with good optical performance, spatial-temporal feature, high sensitivity and selectivity 18 .
However, they are mainly used to monitor pH changes under acidic conditions (pH < 5.5). Currently, there are no a small molecule probes able to accurately differentiate pH values of cancer cells from normal cells.
It has been well-documented that galactose can be recognized by asialoglycoprotein receptor (ASGPR) overexpressed on the hepatocytes [19] [20] [21] [22] [23] [24] . On the other hand, organic molecules bearing a phosphate or phosphoric acid group such as Sofosbuvir and Adefovir were found to easily accumulate in liver (ProTide technology) 25, 26 . However, the hepatocyte-targeting capacity of either galactose or phosphate is still unsatisfactory. In our efforts to develop a simple, efficient, and accurate method to distinguish cancerous liver cells from normal liver cells, galactose and phosphate have been integrated in this study as a dual hepatocyte-targeting motif with the rhodamine derivative as a pH-responsive fluorophore. On the basis of this, a novel small molecule dual hepatocyte-targeting probe (HPL-1) for specific detection of HCC has been developed for the first time (Fig. 1) . C NMR spectra were recorded on a Bruker 600 MHz (Switzerland) at 25 °C, with TMS as the internal standard in CDCl3, and the solvent peak as the internal reference in CD3OD. MS analysis was performed with a Thermo Fisher Scientific LTQ FT Ultra (USA). The UV-vis absorption and fluorescence spectra were obtained with a Shanghai JingHua 7600 UV-visible spectrophotometer (dual beam) (China) and a Shimadzu RF-5301PC (Japan) at room temperature, respectively. The cytotoxicity assays were conducted using ELX800 absorbance microplate reader. Cell image assays were performed by Multi-photon laser confocal scanning microscopy (a LEICA-TCS-SP8MP) (Germany).
Synthesis of HPL-1.
Synthesis of HPL-1 commenced with the cyclization of 2-(4-diethylamino)-2-hydroxybenzoyl)benzoic acid and resorcinol under acidic conditions to give a rhodamine derivatives 1 27 . Esterification of this compound with dimethylcarbamoyl chloride afforded the carbamate compound 2. Treatment of compound 2 with ethanolamine provided the amide compound 3 which was subsequently converted to the phosphate compound 6 with phenyl dichlorophosphate followed by the primary amine 5. Then, the alkyne compound 6 underwent a click reaction to generate the triazole compound 8 which provided the desired molecule HPL-1 upon saponification (Scheme 1). The structures of all compounds were characterized by 1 H NMR, 13 C NMR, and MS spectrometry (Supplementary Information). 
Spectral testing
The probe HPL-1 was dissolved in DMSO to prepare a 1 mM stock solution. Take 100 μL stock solution in a 5 mL centrifuge tube, then set the volume to 5 mL with different pH buffer solution to form 20 μM HPL-1 solution. The test solution is poured into the cuvette. UV spectral scanning range is 200 nm-800 nm. Fluorescence spectrum scanning range is 300 nm-700 nm. Slit width is 3 nm×3 nm.
Cell culture and Confocal Microscopy Imaging
HepG2 cells were incubated with 20 μM HPL-1 for 30 min at 37°C. Then, the cells were washed with PBS for three times and fixed with 4% paraformaldehyde for 15 min at room temperature. After washing with PBS for three times, the cells were soaked in buffer solution (pH 6.5) and buffer solution (pH 7.4) for 10 min, respectively.
HepG2 cells were incubated with 20 μM HPL-1 for 30 min at 37°C. Then, the cells were washed with PBS for three times and fixed with 4% paraformaldehyde for 15 min.
After washing with PBS for three times, HepG2 cells were soaked in buffer solution (pH 6.5) for 10 min, and L02 cells were soaked in buffer solution (pH 7.4) for 10 min.
HepG2, A549, SGC-7901 and Hela cells were treated with 20 μM HPL-1 for 30 min at 37°C. Subsequently, the cells were washed with PBS for three times and fixed with 4% paraformaldehyde for 15 min. After washing with PBS for three times, the cells were soaked in buffer solution (pH 6.5) for 10 min.
HepG2 cells were incubated with 20 μM Compound 3 (without phosphate group and gatactose group), Compound 6 (with phosphate group) and HPL-1 (with phosphate and gatactose groups) for 30 min at 37°C, respectively. Subsequently, the cells were washed with PBS for three times and fixed with 4% paraformaldehyde for 15 min. After washing with PBS for three times, the cells were treated by buffer solution (pH 6.5) for 10 min.
To illuminate localization of HPL-1 in lysosome, HepG2 cells were seeded in glass bottom dish to incubate for 24 h at 37 °C under 5% CO2. Then, the cells were incubated with LysoTracker (500 nM) for 30 min. Next, the cells were washed by PBS for three times and treated by HPL-1 (20 μM) for another 30 min. Finally, the cells were washed thrice with PBS.
All fluorescence images were collected with Multi-photon laser confocal scanning microscopy (Germany). Probes were excited at 488 nm and their green emissions were collected in the range of 490−530 nm. More experimental details were shown in the results and discussion.
Cytotoxicity assays.
HepG2 cells were seeded in 96-well plates with a density of 6000 cells per well and incubated for 24 h at 37 °C under 5% CO2. Then, the cells were treated with the different concentrations of HPL-1 (0-20 μM) for 48 h. Subsequently, 10 μL MTT (5 mg/ml) was added to incubate for 4 h. After that, the medium was replaced by 150 μL DMSO. After gentle shaking for 10 min, and the OD values were recorded by an ELX800 absorbance plate reader (USA) at 490 nm.
Results and Discussion

Spectral Properties of HPL-1 at Different pH Values
To explore the sensitivity of HPL-1 toward the pH values, the fluorescence titration experiments were carried out (Fig. 2) . It was noticed that the fluorescence spectra of HPL-1 solution shows two distinct peaks at pH 6.5 and pH 7.4. Additionally, the fluorescence intensity of this compound at pH 6.5 is obviously stronger than that at pH 7.4. Presumably, HPL-1 adopts a non-conjugated closed-ring lactam conformation at pH 7.4 with weak fluorescence from the rhodamine moiety. Once the pH value is decreased to 6.5, the lactam ring of HPL-1 could be opened to give an extended conjugated system with strong fluorescent 28, 29 . Clearly, HPL-1 is a highly pH-sensitive probe in the narrow range of pH 6.0~7.5, and is capable of monitoring the pH change in weak acidic environment. Thus, HPL-1 has the potential to distinguish cancer cells with the pH value of 6.2~6.9 from normal cells (pH 7.2~7.4). To illuminate the effect of phosphate group of HPL-1 on the sensitivity toward the pH values, the fluorescence properties of Compound 3 without phosphate group toward the pH value were comparatively analyzed (Fig. S1) . From Fig. S1 and Fig. 2, HPL-1 and Compound 3 present similar fluorescence tendency, but HPL-1 shows stronger fluorescence intensity than Compound 3, suggesting that the introduction of phosphate group does not modify detection range of pH values (6.0~7.5), but it is beneficial for the sensitivity toward the pH value. 
Cellular pH sensitivity of HPL-1 at pH 6.5 and 7.4
To further explore whether HPL-1 can accurately distinguish weak acid environment of cancer cells from weak basic environment of normal cells, cell imaging experiments of HPL-1 at pH 6.5 and 7.4 were performed. As shown in Fig. 3 , the fluorescence intensity of HPL-1 in the cells with medium pH of 6.5 was about 4 times that of HPL-1 in the cells with medium pH of 7.4, being consistent with the fluorescence spectra in vitro. This result suggests that HPL-1 can be used to accurately distinguish cancer cell micro-environment (pH 6.5) from normal cell micro-environment (pH 7.4). 
Cell imaging of HPL-1 in normal liver cells (L02) and hepatocellular carcinoma cells (HepG2 cell)
Next, we conducted a comparative cell imaging experiment of HPL-1 in normal liver cells (L02) and cancerous liver cells (HepG2) to identify whether HPL-1 can accurately distinguish cancerous liver cells from normal liver cells. As shown in Fig. 4 , the fluorescence intensity of HPL-1 in HepG2 cells was about 6 times that of HPL-1 in normal liver cells (L02), implying that HPL-1 can be used to accurately distinguish cancerous liver cells from normal liver cells. When Fig. 3 and Fig. 4 
Cell imaging of HPL-1 in hepatocellular carcinoma cells (HepG2 cell) and other tissue cells
We then performed hepatocyte-targeting cell imaging experiments to exploit whether HPL-1 is able to selectively distinguish hepatocellular carcinoma cells from other tissue cells (Fig. 5) . It was found that although all of these cells showed green fluorescence, the fluorescence intensity of the HepG2 cell was about 6 times that of A549 cell, 15 times that of SGC-7901, and 12 times that of HeLa. These results suggest 
The contribution of the HPL-1 fragment on liver-targeting capacity
To probe the role of key fragments of HPL-1 on hepatocyte-targeting capacity, two representative compounds 3 without phosphate group and gatactose group, Compound 6 with phosphate group were prepared comparatively analyzed. As shown in Fig. 6 , the fluorescence intensity of Compound 6 was stronger than that of compound 3, indicating that the phosphate modification is beneficial for the hepatocyte-targeting strategy. The fluorescence intensity of HPL-1 is significantly stronger than that of compound 6, suggesting that the introduction of galactose group is favourable for hepatocyte-targeting capacity, which is attributed to the specific recognization of the galactose unit of HPL-1 on ASGPR overexpressed on the hepatocytes. Furthermore, HPL-1 exhibited much higher fluorescence intensity than Compound 3 and Compound 6，showing that the co-modification with phosphate and galactose groups could synergistically improve hepatocyte-targeting effect of compounds, which is attributed to the superposition effect of phosphate and galactose. 
Galactose inhibition test
To further illuminate the contribution of galactose on the hepatocyte-targeting capacity of HPL-1, we performed galactose competition experiments. As shown in Fig.   7 , the fluorescence intensity of HPL-1 gradually decreased with the addition of galactose (0-40 μM), and the fluorescence can hardly be observed when galactose reached 40 μM. These results demonstrate that the specific recognition of galactose group on ASGPR is one of driving forces for the hepatocyte-targeting capacity of HPL-1. Lysosome has been reported as an acid production center (pH 3.8-5.0) in living cells and may be directly related to an acidic micro-environment of cancer cells 30 . Therefore, it is very significant to illuminate whether HPL-1 can reach intracellular lysosome. In 
Cytotoxicity
Low toxicity is an important requirement for fluorescent probes used in biological systems. As shown in Fig. 9 , after HepG2 cells were incubated with HPL-1 (<10 μM) for 24 hours, the cell viability was nearly 100%. Even when the concentration of HPL-1 was increased to 20 μM, the cell viability was still above 80%. Clearly, HPL-1 could be harmlessly used to detect hepatoma cells in biological system. The possible reason is that HPL-1 contains biocompatible phosphate and galactose groups. The above results showed that compared with other pH fluorescent probes (Table S1 ), HPL-1 possesses the most narrow detection range of pH (6.4-6.7), which corresponds to the pH range of cancer micro-environment. Moreover, HPL-1 showed excellent hepatocyte-targeting capacity (particularly for hepatoma cells).
Conclusion
A new dual hepatocyte-targeting fluorescent probe (HPL-1) has been developed in this study. This molecule switches on at tumorous micro-environment (pH 6.5), but switches off at physiological micro-environment (pH 7.4). HPL-1 can distinguish hepatoma cells from other tissue cells, and it represents the first example of small molecules for specific hepatoma cell targeting. The observed hepatocyte-targeting capacity trend with compounds 3, 6 and HPL-1 indicates that while phosphate modification is an efficient hepatocyte-targeting strategy, and co-modification with phosphate and the galactose unit could synergistically improve hepatocyte-targeting effect of compounds. More importantly, HPL-1 can precisely distinguish cancerous liver cells from normal liver cells via accurate response to adjacent tumorous and physiological pH. Moreover, the observed low-toxicity and ready availability of HPL-1 are beneficial to the detection of hepatoma cells in vitro, and is of great significance for the early diagnosis and precise treatment of hepatocellular carcinoma.
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